TL Genomics: 200 diseases discrimination with prenatal diagnosis – fetal cell analysis

TL Genomics: 200 diseases discrimination with prenatal diagnosis – fetal cell analysis

Japanese venture · TL Genomics developed application technology for prenatal testing.

Separate and analyze fetal cells contained in trace amounts in maternal blood.

Multilayered resin substrates with fine grooves

Injecting blood into the microfluidic chip

Sort and analyze fetal cells based on the size of the cells

Since it examine the cell itself, it is more accurate than the existing testing method for examining DNA fragments and many diseases that can be examined.

In the United States where prenatal testing is widespread, we aim to put it into practical use within two years.

Chemical Industry Daily

https://www.chemicaldaily.co.jp/

https://www.nikkan.co.jp/articles/view/00498048